Putting The Spotlight On Coherus Biosciences Inc (CHRS)
Coherus Biosciences Inc (NASDAQ:CHRS) currently has a daily average trading volume of 5.19M but it saw 3153885 shares traded in last market. With a market cap of 180.88M USD, the company’s current market price of $1.57 came falling about -8.19 while comparing to the previous closing price of $1.71. In past 52 weeks, the stock […]
Do Investors Have Much Faith In Coherus Biosciences Inc (NASDAQ: CHRS)
Coherus Biosciences Inc (NASDAQ:CHRS) does about 5.27M shares in volume on a normal day but saw 2544064 shares change hands in the recent trading day. The company now has a market cap of 199.09M USD. Its current market price is $1.61, marking an increase of 7.33% compared to the previous close of $1.50. The 52 […]
Coherus Biosciences Inc (CHRS) Reports -54.05% Fall From For 52 Week High, It’s Always Darkest Before The Dawn
Coherus Biosciences Inc (NASDAQ:CHRS) does about 5.08M shares in volume on a normal day but saw 5691559 shares change hands in the recent trading day. The company now has a market cap of 220.50M USD. Its current market price is $1.70, marking no change compared to the previous close of $1.70. The 52 week high […]
With 115.21M Outstanding Shares, Can Coherus Biosciences Inc (NASDAQ: CHRS) Deliver Big Short-Term Gains?
Coherus Biosciences Inc (NASDAQ:CHRS) currently has a daily average trading volume of 4.92M but it saw 7644645 shares traded in last market. With a market cap of 173.97M USD, the company’s current market price of $1.51 came falling about -11.70 while comparing to the previous closing price of $1.71. In past 52 weeks, the stock […]
More To Go Or Is It Over? – Coherus Biosciences Inc (CHRS)
Coherus Biosciences Inc (NASDAQ:CHRS) does about 2.89M shares in volume on a normal day but saw 4293584 shares change hands in the recent trading day. The company now has a market cap of 152.83M USD. Its current market price is $1.37, marking an increase of 12.30% compared to the previous close of $1.22. The 52 […]
Coherus Biosciences Inc (NASDAQ: CHRS) Emerges As Guiding Light For Investors
Coherus Biosciences Inc (NASDAQ:CHRS) currently has a daily average trading volume of 2.82M but it saw 3270719 shares traded in last market. With a market cap of 142.90M USD, the company’s current market price of $1.26 came falling about -1.56 while comparing to the previous closing price of $1.28. In past 52 weeks, the stock […]
Things For Investors To Watch In Coherus Biosciences Inc (NASDAQ: CHRS)
Coherus Biosciences Inc (NASDAQ:CHRS) does about 2.66M shares in volume on a normal day but saw 7431149 shares change hands in the recent trading day. The company now has a market cap of 139.41M USD. Its current market price is $1.21, marking an increase of 11.01% compared to the previous close of $1.09. The 52 […]
Coherus Biosciences Inc (NASDAQ: CHRS) Recovers 66.59% From 52-Week Low, Is CHRS Still A High-Risk, High-Reward Play?
Coherus Biosciences Inc (NASDAQ:CHRS) currently has a daily average trading volume of 2.59M but it saw 5071162 shares traded in last market. With a market cap of 126.73M USD, the company’s current market price of $1.10 remained unchanged while comparing to the previous closing price of $1.10. In past 52 weeks, the stock remained buoying […]
Coherus Biosciences Inc (CHRS) Reports -79.89% Fall From For 52 Week High, It’s Always Darkest Before The Dawn
Coherus Biosciences Inc (NASDAQ:CHRS) does about 2.55M shares in volume on a normal day but saw 3004136 shares change hands in the recent trading day. The company now has a market cap of 82.55M USD. Its current market price is $0.74, marking a decrease of -3.70% compared to the previous close of $0.77. The 52 […]
Coherus Biosciences Inc (NASDAQ: CHRS): Retirees Don’t Worry About Volatility
Coherus Biosciences Inc (NASDAQ:CHRS) currently has a daily average trading volume of 2.52M but it saw 2360191 shares traded in last market. With a market cap of 89.72M USD, the company’s current market price of $0.78 came falling about -5.44 while comparing to the previous closing price of $0.82. In past 52 weeks, the stock […]
